List of Excipients in API rydapt
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing rydapt
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Novartis Pharmaceuticals Corporation | RYDAPT | rydapt | 0078-0698 | .ALPHA.-TOCOPHEROL | |
| Novartis Pharmaceuticals Corporation | RYDAPT | rydapt | 0078-0698 | ALCOHOL | |
| Novartis Pharmaceuticals Corporation | RYDAPT | rydapt | 0078-0698 | CARMINIC ACID | |
| Novartis Pharmaceuticals Corporation | RYDAPT | rydapt | 0078-0698 | CORN OIL | |
| Novartis Pharmaceuticals Corporation | RYDAPT | rydapt | 0078-0698 | FERRIC OXIDE RED | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for rydapt
Excipient focus: .ALPHA.-TOCOPHEROL
rydapt drug variants containing .ALPHA.-TOCOPHEROL
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | rydapt | 0078-0698 |
| >Company | >Ingredient | >NDC |
rydapt drug variants not containing .ALPHA.-TOCOPHEROL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: ALCOHOL
rydapt drug variants containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | rydapt | 0078-0698 |
| >Company | >Ingredient | >NDC |
rydapt drug variants not containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CARMINIC ACID
rydapt drug variants containing CARMINIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | rydapt | 0078-0698 |
| >Company | >Ingredient | >NDC |
rydapt drug variants not containing CARMINIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CORN OIL
rydapt drug variants containing CORN OIL
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | rydapt | 0078-0698 |
| >Company | >Ingredient | >NDC |
rydapt drug variants not containing CORN OIL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
rydapt drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | rydapt | 0078-0698 |
| >Company | >Ingredient | >NDC |
rydapt drug variants not containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
rydapt drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | rydapt | 0078-0698 |
| >Company | >Ingredient | >NDC |
rydapt drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: GELATIN
rydapt drug variants containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | rydapt | 0078-0698 |
| >Company | >Ingredient | >NDC |
rydapt drug variants not containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERIN
rydapt drug variants containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | rydapt | 0078-0698 |
| >Company | >Ingredient | >NDC |
rydapt drug variants not containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2910
rydapt drug variants containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | rydapt | 0078-0698 |
| >Company | >Ingredient | >NDC |
rydapt drug variants not containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 400
rydapt drug variants containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | rydapt | 0078-0698 |
| >Company | >Ingredient | >NDC |
rydapt drug variants not containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYOXYL 40 HYDROGENATED CASTOR OIL
rydapt drug variants containing POLYOXYL 40 HYDROGENATED CASTOR OIL
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | rydapt | 0078-0698 |
| >Company | >Ingredient | >NDC |
rydapt drug variants not containing POLYOXYL 40 HYDROGENATED CASTOR OIL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
rydapt drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | rydapt | 0078-0698 |
| >Company | >Ingredient | >NDC |
rydapt drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
rydapt drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | rydapt | 0078-0698 |
| >Company | >Ingredient | >NDC |
rydapt drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
rydapt drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | rydapt | 0078-0698 |
| >Company | >Ingredient | >NDC |
rydapt drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch